A Hospital costs for disposable supplies | ||||
---|---|---|---|---|
Hospital cost classification | Hospital costs for disposable supplies | |||
Variables | Coefficient | 95% CI | P value | |
Lower | Upper | |||
Intercept | 9.279 | 9.203 | 9.357 | < 0.001 |
Powered stapler vs. Manual stapler | −0.007 | − 0.084 | 0.069 | 0.854 |
Demographics | ||||
Male vs. female | 0.041 | −0.048 | 0.129 | 0.361 |
BMI | ||||
18.5 < =BMI < 24 vs. Other BMI distribution ranges | −0.099 | − 0.171 | − 0.028 | 0.007 |
24 < =BMI < 28 vs. Other BMI distribution ranges | −0.133 | − 0.214 | − 0.052 | 0.001 |
30 < =BMI < 40 vs. Other BMI distribution ranges | −0.388 | − 0.624 | − 0.134 | 0.002 |
Tumor histology | ||||
Adenocarcinoma vs. Non-adenocarcinoma | −0.041 | − 0.108 | 0.025 | 0.225 |
Tumor stage | ||||
Stage I vs. Non-stage I | 0.058 | −0.005 | 0.120 | 0.072 |
Bone marrow function | ||||
Abnormal INR vs. Normal INR | 0.141 | −0.022 | 0.311 | 0.099 |
Abnormal hemoglobin vs. Normal hemoglobin | 0.076 | − 0.004 | 0.157 | 0.066 |
Lobectomy site | ||||
Upper left vs. Non-upper left site | −0.026 | − 0.100 | 0.050 | 0.500 |
Comorbidity | ||||
Hypertension vs. Non-hypertension | −0.051 | − 0.128 | 0.026 | 0.193 |
Immune system diseases vs. Non-immune system diseases | 0.177 | −0.193 | 0.583 | 0.355 |
Breast diseases vs. Non-breast diseases | −0.524 | − 0.917 | − 0.075 | 0.015 |
B. Hospital for drugs | ||||
Hospital cost classification | Hospital costs for drugs | |||
Variables | Coefficient | 95% CI | P value | |
Lower | Upper | |||
Intercept | 9.492 | 9.337 | 9.649 | < 0.001 |
Powered stapler vs. Manual stapler | −0.256 | −0.375 | −0.139 | < 0.001 |
Demographics | ||||
Male vs. female | 0.041 | −0.048 | 0.129 | 0.361 |
BMI | ||||
24 < =BMI < 28 vs. Other BMI distribution ranges | −0.148 | − 0.250 | − 0.044 | 0.005 |
28 < =BMI < 30 vs. Other BMI distribution ranges | −0.330 | − 0.535 | − 0.112 | 0.002 |
Residence city | ||||
County vs. Other cities | 0.134 | −0.002 | 0.273 | 0.058 |
Marital status | ||||
Married vs. Other marital status | −0.010 | −0.129 | 0.106 | 0.864 |
Public health insurance plan | ||||
Urban worker insurance plan vs. other insurance plan | −0.049 | − 0.155 | 0.058 | 0.367 |
Tumor histology | ||||
Adenocarcinoma vs. Non-adenocarcinoma | 0.018 | −0.074 | 0.109 | 0.702 |
Tumor stage | ||||
Stage I vs. Non-stage I | −0.153 | −0.240 | − 0.067 | < 0.001 |
Bone marrow function | ||||
Abnormal platelet counts vs. normal platelet counts | 0.233 | 0.085 | 0.386 | 0.002 |
Lobectomy site | ||||
Upper left vs. Non-upper left site | 0.029 | −0.071 | 0.131 | 0.576 |
Comorbidity | ||||
Diabetes vs. Non-diabetes | 0.124 | −0.017 | 0.270 | 0.091 |
Cerebrovascular diseases vs. Non-cerebrovascular diseases | 0.095 | −0.018 | 0.210 | 0.103 |
Urological diseases vs. Non-urological diseases | 0.144 | 0.045 | 0.246 | 0.005 |
Cardiovascular diseases vs. Non-cardiovascular diseases | 0.073 | −0.066 | 0.217 | 0.310 |
Endocrine diseases vs. Non-endocrine diseases | −0.164 | − 0.297 | − 0.026 | 0.019 |
C. Hospital costs related to operation | ||||
Hospital cost classification | Hospital costs related to operation | |||
Variables | Coefficient | 95% CI | P value | |
Lower | Upper | |||
Intercept | 8.925 | 8.856 | 8.994 | < 0.001 |
Powered stapler vs. Manual stapler | 0.004 | −0.065 | 0.072 | 0.909 |
Tumor stage | ||||
Stage I vs. Non-stage I | −0.052 | − 0.110 | 0.006 | 0.079 |
Lobectomy site | ||||
Upper left vs. Non-upper left site | 0.002 | −0.070 | 0.075 | 0.954 |
Comorbidity | ||||
Bronchial diseases vs. Non-bronchial diseases | 0.108 | 0.015 | 0.203 | 0.025 |
Immune system diseases vs. Non-immune system diseases | −0.393 | − 0.707 | − 0.047 | 0.019 |
Cerebrovascular diseases vs. Non-cerebrovascular diseases | 0.040 | −0.038 | 0.120 | 0.316 |
Urological diseases vs. Non-urological diseases | 0.074 | 0.002 | 0.146 | 0.045 |
Cardiovascular diseases vs. Non-cardiovascular diseases | 0.066 | −0.032 | 0.167 | 0.196 |
Sport system diseases vs. Non-sport system diseases | 0.071 | −0.033 | 0.178 | 0.186 |
Vascular diseases vs. Non-vascular diseases | 0.088 | − 0.142 | 0.334 | 0.472 |
D. Hospital costs for laboratory tests | ||||
Hospital cost classification | Hospital costs for laboratory tests | |||
Variables | Coefficient | 95% CI | P value | |
Lower | Upper | |||
Intercept | 9.133 | 8.851 | 9.417 | < 0.001 |
Powered stapler vs. Manual stapler | −0.094 | −0.203 | 0.014 | 0.082 |
Demographics | ||||
Age | 0.002 | −0.003 | 0.007 | 0.367 |
18.5 < =BMI < 24 vs. Other BMI distribution ranges | 0.100 | 0.013 | 0.188 | 0.024 |
Public health insurance plan | ||||
Urban worker insurance plan vs. Other insurance plans | ||||
New rural cooperative medical insurance vs. Other insurance plans | −0.029 | − 0.128 | 0.071 | 0.562 |
Tumor histology | ||||
Adenocarcinoma vs. Non-adenocarcinoma | −0.031 | − 0.117 | 0.055 | 0.480 |
Tumor stage | ||||
Stage I vs. Non-stage I | −0.033 | − 0.113 | 0.048 | 0.427 |
Bone marrow function | ||||
Abnormal white cell counts vs. Normal white cell counts | −0.117 | −0.256 | 0.026 | 0.101 |
Lobectomy site | ||||
Upper left vs. Non-upper left site | 0.014 | −0.082 | 0.111 | 0.781 |
Comorbidity | ||||
Immune system diseases vs. Non-immune system diseases | −0.521 | − 0.944 | − 0.039 | 0.023 |
Diabetes vs. Non-diabetes | 0.165 | 0.030 | 0.305 | 0.019 |
Cerebrovascular diseases vs. Non-cerebrovascular diseases | 0.046 | −0.063 | 0.157 | 0.415 |
Urological diseases vs. Non-urological diseases | 0.133 | 0.038 | 0.230 | 0.007 |
Cardiovascular diseases vs. Non-cardiovascular diseases | 0.088 | −0.046 | 0.225 | 0.206 |
E. Other hospital costs | ||||
Hospital cost classification | Other hospital costs | |||
Variables | Coefficient | 95% CI | P value | |
Lower | Upper | |||
Intercept | 7.707 | 7.618 | 7.798 | < 0.001 |
Powered stapler vs. Manual stapler | −0.008 | −0.099 | 0.080 | 0.854 |
Tumor stage | ||||
Stage I vs. Non-stage I | −0.083 | −0.159 | − 0.007 | 0.033 |
Lobectomy site | ||||
Upper left vs. Non-upper left | −0.019 | −0.111 | 0.075 | 0.684 |
Comorbidity | ||||
Immune system diseases vs. Non-immune system diseases | −0.410 | −0.817 | 0.054 | 0.064 |
Diabetes vs. Non-diabetes | 0.158 | 0.028 | 0.292 | 0.020 |
Cerebrovascular diseases vs. Non-cerebrovascular diseases | 0.068 | −0.033 | 0.172 | 0.195 |
Urological diseases vs. Non-urological diseases | 0.176 | 0.084 | 0.269 | < 0.001 |